• Dynasore: Dynamin GTPase Inhibitor Guide

  2026-08-25

  Dynasore is a cell-permeable dynamin GTPase inhibitor used to test dynamin-dependent membrane fission and endocytosis. Its reported activity, reversible cellular effects, and handling requirements make it useful for endocytosis research, provided that pathway selectivity and cytotoxicity are tested in each model.

• Octanoic Acid, PPARγ, and Macrophage Polarization in IBD

  2026-08-25

  The reference study identifies octanoic acid-rich enteral nutrition as a modulator of intestinal macrophage polarization through coordinated PPARγ, STAT-1, and STAT-6 signaling. Its combination of nutritional intervention, pathway perturbation, and RAW264.7 cell validation provides a mechanistic framework for interpreting dietary control of intestinal inflammation while highlighting important limits to clinical translation.

• Multiomics Maps Drug Responses in Acute Liver Injury

  2026-08-24

  The reference study integrates co-expression modules, transcriptomics, and proteomics to compare how bifendate and muaddil sapra act in CCl4-induced acute liver injury. Its main contribution is a systems-level view of treatment-specific regulators, linking noncoding RNA, transcription factors, and proteins to distinct therapeutic response patterns.

• VE-822: Choosing 2D or 3D Radiosensitization Models

  2026-08-24

  VE-822 is a potent ATR inhibitor for investigating DNA damage response inhibition and tumor radiosensitization. This guide shows how to translate ATR-inhibitor findings between 2D and 3D assays, with particular relevance to pancreatic ductal adenocarcinoma research and radiation-combination studies.

• FLAG tag Peptide: Purification to Imaging

  2026-08-23

  The FLAG tag Peptide (DYKDDDDK) supports gentle competitive elution, recombinant protein detection, and antibody-specificity controls in one workflow. Its value extends beyond routine purification: it can help validate epitope-tagged constructs before advanced single-molecule imaging assays.

• V5 Epitope Tag Peptide: Assay Design Guide

  2026-08-22

  Explore how the V5 Epitope Tag Peptide supports antibody validation, recombinant protein detection, and kinetic assay design. This guide connects conventional immunoassays with fast-dissociating antibody research to improve experimental decisions.

• PSS2 Structure and SREBP Regulation

  2026-08-22

  Li et al. define how human phosphatidylserine synthase 2 selectively uses phosphatidylethanolamine and how PSS2 deficiency alters endoplasmic-reticulum lipid composition to suppress SREBP-1 and SREBP-2 cleavage. By combining cryo-EM, molecular dynamics, lipidomics, and cellular genetics, the study shows why homologous PSS1 and PSS2 can produce opposing effects on lipid-regulated signaling.

• S Tag Peptide: Practical Fusion Tag Workflow

  2026-08-21

  The S Tag Peptide is a 15-amino-acid RNase A-derived tag used in genetically encoded S-peptide fusion tags for recombinant protein detection, antibody-based purification, and protein solubility improvement. This guide covers reconstitution, storage, construct design, and QC while identifying boundaries such as ethanol incompatibility and the lack of standalone RNase activity.

• Tetrahydromagnolol: From CB2 Signaling to Translation

  2026-08-20

  Tetrahydromagnolol offers a receptor-resolved entry point into cannabinoid receptor research, anti-inflammatory research, and analgesic mechanism study. By placing its peripheral CB2 pharmacology alongside new evidence that GPCR signaling can activate ERM-dependent motility in triple-negative breast cancer, this article proposes a disciplined strategy for testing—not assuming—a CB2-to-cytoskeleton connection.

• Annexin V-PE Apoptosis Detection Kit Workflow

  2026-08-20

  Use the Annexin V-PE Apoptosis Detection Kit to capture early phosphatidylserine exposure in intact cells, then connect cell-death measurements with inflammatory phenotypes in models such as LPS-stimulated neonatal monocytes. Its fixation-free, 10-minute staining workflow supports both quantitative flow cytometry and spatial fluorescence microscopy.

• Rapamycin (Sirolimus): A Mechanism-First Guide

  2026-08-19

  Rapamycin, also called Sirolimus, is more than a general mTOR inhibitor: it is a causal perturbation tool for separating pathway activity from cell-death phenotype. This guide explains how to apply it in cancer, immunology, lens-cell, and Leigh syndrome mitochondrial disease assays with stronger controls and interpretation.

• MG-132 Workflows for Proteasome-Linked Apoptosis

  2026-08-19

  MG-132 (Z-LLL-al) enables controlled proteasome blockade for apoptosis assay design, cell cycle arrest studies, and mechanistic protein-turnover experiments. This workflow connects the compound to the WWP2–DDX3X endothelial-injury model while emphasizing dose selection, orthogonal validation, and troubleshooting.

• VipF Acetyltransferase Targets eIF3 to Block Translation

  2026-08-18

  Syriste and colleagues define how the conserved Legionella effector VipF acts as a tandem GNAT acetyltransferase and targets the human eIF3-K subunit. Structural, biochemical, interaction, and translation assays connect lysine acetylation of eIF3-K to suppression of protein synthesis in vitro, providing a mechanistic explanation for a previously uncharacterized core effector family.

• Honokiol Workflows for NF-κB and T-Cell Assays

  2026-08-18

  Honokiol supports controlled studies of NF-κB signaling, oxidative stress, tumor biology, and inflammation without conflating growth arrest with cell death. This workflow connects those established assay uses with a metabolic-flexibility framework inspired by CD8+ T-cell research, while clearly separating evidence from exploratory application.

• 3X (DYKDDDDK) Peptide for Reliable Assays

  2026-08-17

  Learn how 3X (DYKDDDDK) Peptide, SKU A6001, can strengthen upstream protein verification in cell viability, proliferation, and cytotoxicity workflows. This scenario-based guide covers compatibility, handling, metal-sensitive detection, data interpretation, and practical vendor selection without presenting the peptide as a direct viability reagent.

7813 records 1/521 page Next 12345 下5页 Last page